Skip to Main Content

Paper Details

CRISPR/Cas9 as a tool to dissect cancer mutations.
Methods
4
2019
Author NameAffiliation
Maciej Paszkowski-Rogacz
Frank BuchholzGermany National Center for Tumor Diseases (NCT), University Hospital Carl Gustav Carus, Germany German Cancer Research Center (DKFZ), Germany Max Planck Institute of Molecular Cell Biology and Genetics
  • 1 - 2

Datasets

Release 1.2